RhoGTPases and their role in cancer

Related Experiment Video

Updated: Sep 26, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

Xiaoyu Li1, Bing Lim

  • 1Cancer Biology, HIM 955 Harvard Institutes of Medicine, Beth Israel Deaconess Medical Center, 77 Avenue Louis Pasteur, Boston, MA 02115, USA.

Oncology Research
|May 3, 2003
PubMed

Insights

Rho GTPases are key regulators of cell functions. Aberrant Rho GTPase activity may contribute to cancer development, highlighting potential new diagnostic and therapeutic strategies for human cancers.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Oncology

Background:

  • Rho GTPases are critical regulators of cellular processes, including growth and differentiation.
  • Dysregulation of Rho GTPase signaling pathways is implicated in various diseases.
  • Their role in cancer pathogenesis is an area of active investigation.

Purpose of the Study:

  • To review the current evidence linking Rho GTPase function to human cancer.
  • To highlight the potential of Rho GTPases as biomarkers and therapeutic targets in oncology.
  • To underscore the importance of understanding Rho GTPase signaling in cancer biology.

Main Methods:

  • Literature review and synthesis of existing research findings.
  • Analysis of studies investigating Rho GTPase expression and activity in cancer tissues.
  • Evaluation of experimental data on the functional impact of Rho GTPases in cancer models.

Main Results:

  • While direct causative links are still emerging, accumulating evidence suggests a role for Rho GTPases in carcinogenesis and cancer progression.
  • Specific Rho GTPases have been found to be aberrantly expressed or activated in various human cancers.
  • Perturbed Rho GTPase signaling can influence tumor cell proliferation, migration, invasion, and angiogenesis.

Conclusions:

  • Rho GTPases represent a promising area for cancer research, with potential implications for early diagnosis and treatment.
  • Further investigation is warranted to elucidate the precise mechanisms by which Rho GTPases contribute to cancer.
  • Targeting Rho GTPase pathways may offer novel therapeutic strategies for cancer patients.

More Related Videos

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay13:51

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

Published on: November 11, 2018

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...